Table 4 Participant post-musculoskeletal injury outcome classifications

Recurrent MSKI

No new MSKI within 6 months of RTD/A following cessation of treatment for the index MSKI

Same MSKI at the same location as the index MSKI within 6 months of RTD/A following cessation of treatment for the index MSKI

Subsequent MSKI condition

No new MSKI within 6 months of RTD/A following cessation of treatment for the index MSKI

A new MSKI at a different location as the index MSKI within 6 months of RTD/A following cessation of treatment for the index MSKI

Chronification [47]

Index MSKI signs/symptoms resolve within 12 weeks

Index MSKI signs/symptoms do not resolve within 12 weeks

Delayed RTD/A

RTD/A prior to 2 standard deviations greater than the mean number of limited duty days for our total sample

RTD/A more than 2 standard deviations greater than or equal to the mean number of limited duty days for our total sample

PROMIS physical function

Physical Function score is greater than 1 standard deviation less than the mean Physical Function score for our total sample at the 12 week follow-up for the index MSKI

Physical Function score is less than or equal to 1 standard deviation less than the mean Physical Function score for our total sample at the 12 week time point for the index MSKI

PROMIS pain interference

Pain Interference score is less than 1 standard deviation greater than the mean Pain Interference score for our total sample at the 12 week follow-up for the index MSKI

Pain Interference score is greater than or equal to 1 standard deviation greater than the mean Pain Interference score for our total sample at the 12 week follow-up for the index MSKI

TSK-11

TSK-11 score is less than 1 standard deviation greater than the mean TSK-11 score for our total sample at the 12 week follow-up for the index MSKI

TSK-11 score is greater than or equal to 1 standard deviation greater than the mean TSK-11 score for our total sample at the 12 week follow-up for the index MSKI